Antares Therapeutics, Inc. logo
SEC Form D filing

Antares Therapeutics, Inc.

Biotech · Series C · Regulation D 506(b) · MA · Filed March 12, 2025

Websiteantaresrx.com
Offering amount
$40.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
March 12, 2025
Signature date
—
CIK
0002059043

Summary

Therapeutic biotech at $40M offering stage, typical series-c or later.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.